Susquehanna International Group, LLP Bridge Bio Pharma, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 715,157 shares of BBIO stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
715,157
Previous 676,649
5.69%
Holding current value
$16 Million
Previous $17.1 Million
6.23%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$565 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$561 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$317 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$278 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$136 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.31B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...